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Abstract
The SET-domain protein methyltransferase superfamily includes all but one of the proteins
known to methylate histones on lysine. Histone methylation is important in the regulation of
chromatin and gene expression.
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Gene organization and evolutionary history 
Nucleosomes, the main components of chromatin, consist of
histones, and histone proteins have positively charged
amino-terminal tails that are exposed on the outside of
nucleosomes. These tails are subject to several post-transla-
tional covalent modifications, including acetylation, phos-
phorylation, ubiquitination, sumoylation and methylation
(reviewed in [1]). Methylation been found on a range of
lysine residues in various histones: K4 (using the single-
letter amino-acid code for lysine), K9, K27, K36 and K79 in
histone H3, K20 in histone H4, K59 in the globular domain
of histone H4 [2] and K26 of histone H1B [3]. Several pro-
teins responsible for the methylation of specific residues
have been characterized, and all but one of these contains a
SET domain; they make up the SET-domain protein methyl-
transferase family (Table 1). The exception to the rule is the
DOT1 family, members of which methylate K79 in the globu-
lar region of histone H3 and which are structurally not
related to SET-domain proteins [4-6]. Recent work suggests
that SET-domain-containing proteins methylate a few pro-
teins in addition to histones (see later); they should there-
fore be named protein lysine methyltransferases rather than
histone lysine methyltransferases. The function of SET-
domain proteins is to transfer a methyl group from S-adeno-
syl-L-methionine (AdoMet) to the amino group of a lysine
residue on the histone or other protein, leaving a methylated
lysine residue and the cofactor byproduct S-adenosyl-L-
homocysteine (AdoHcy). Methylation of specific histone
lysine residues serves as a post-translational epigenetic
modification that controls the expression of genes by serving
as ‘markers’ for the recruitment of particular complexes that
direct the organization of chromatin. 
The SET domain (Figure 1) was first recognized as a conserved
sequence in three Drosophila melanogaster proteins: a modi-
fier of position-effect variegation, Suppressor of variegation 3-9
(Su(var)3-9) [7], the Polycomb-group chromatin regulator
Enhancer of zeste (E(z)) [8], and the trithorax-group chro-
matin regulator trithorax (Trx) [9]. The domain, which is
approximately 130 amino acids long, was characterized in 1998
[10] and SET-domain proteins have now been found in all
eukaryotic organisms studied. There are currently 157 entries
for human SET-domain proteins in the SMART database [11]
and 93 entries in the Pfam database [12], although both data-
bases contain duplicate entries. Seven main families of SET-
domain proteins are known - the SUV39, SET1, SET2, EZ, RIZ,
SMYD, and SUV4-20 families - as well as a few orphan
members such as SET7/9 and SET8 (also called PR-SET7; see
Table 2 for a list of the members of each family in humans and
their properties). Proteins within each family have similar
sequence motifs surrounding the SET domain, and they often
also share a higher level of similarity in the SET domain. The SUV39 family has been characterized in most detail.
Members of this family - human SUV39H1, murine
Suv39h2, and Schizosaccharomyces pombe Cryptic loci reg-
ulator 4 (CLR4)  - were the first SET-domain protein lysine
methyltransferases to be characterized, following the discov-
ery of sequence homology between their SET domains [13].
These proteins, with other members of the family such as D.
melanogaster Su(var)3-9, specifically methylate lysine 9 of
histone H3 (H3 K9) [13]. Human SUV39H1 and its closely
related paralog, SUV39H2, are 55% identical at the amino-
acid level. The structures of the genes encoding the two pro-
teins are shown in Figure 2a,b: both have six exons, and they
have identical intron-exon junctions. It appears that
SUV39H1 and SUV39H2 resulted from a recent gene-dupli-
cation event, as only mammals have two copies. The SUV39-
family proteins of the frog Xenopus laevis  (GenBank
accession number AAH70805) and the zebrafish Danio rerio
(AAH76417) are more closely related to human SUV39H1
than to SUV39H2; they share 75% and 63% amino-acid
identity with SUV39H1, respectively. The zebrafish gene also
shares all intron-exon junctions with human, and the frog
gene shares at least four of the junctions. The D.
melanogaster Su(var)3-9 protein is only 30% identical to
human SUV39H1, and their genes share no intron-exon
junctions. The S. pombe member of the SUV39 family,
CLR4, is only 27% identical to the human protein and its
gene contains no introns. 
The members of the SUV39 family discussed above are
involved in both euchromatin and heterochromatin, but
another member of the same family, G9a, is the predomi-
nant histone H3 K9 methyltransferase in mammalian
euchromatin [14]. There are two isoforms of G9a in the
mouse: the short form (GenBank accession number
NP_671493) corresponds to human G9a and the long form
(NP_665829), which lacks intron one, has additional Arg-
Gly repeats at the amino terminus. No human expressed
sequence tag (EST) corresponding to the long form of G9a
has yet been isolated, although the sequence is present in
the genome. Similar to the situation with SUV39H1, G9a
also has a closely related paralog in mammals, G9a-like-
protein-1 (GLP1). The human G9a gene has 28 exons and is
227.2 Genome Biology 2005, Volume 6, Issue 8, Article 227 Dillon et al. http://genomebiology.com/2005/6/8/227
Genome Biology 2005, 6:227
Table 1
Sites and functions of histone lysine methylation
Histone lysine Function(s) Histone lysine methyltransferases*
H1 K26 Transcriptional silencing Hs EZH2 (catalytic subunit of Polycomb repressive complex 3) [3]
H3 K4 Transcriptional activation Dm Trx; Hs MLL1 (ALL-1, HRX), MLL2 (ALR-1), and MLL3 (HALR)
Transcriptional activation and elongation Hs SET1; Sc SET1
Transcriptional activation Hs SET7/9
Transcriptional activation (in conjunction with ASH1-mediated  Dm ASH1
methylation of H3 K9 and H4 K20)
H3 K9 Heterochromatic and euchromatic silencing; DNA methylation  Dm Su(var)3-9; Hs and Mm SUVAR39H1 and UVAR39H2; Sp CLR4
Euchromatic silencing; DNA methylation Hs and Mm G9a; Hs GLP1 (EuHMT1)
Euchromatic silencing Hs and Mm ESET (SETDB1)
Heterochromatic silencing; DNA methylation Nc DIM-5
Heterochromatic silencing; DNA methylation At KRYPTONITE
Transcriptional activation (in conjunction with ASH1-mediated  Dm ASH1
methylation of H3 K4 and H4 K20)
H3 K27 Euchromatic silencing Dm E(z); Hs EZH1 and EZH2 (catalytic subunit of Polycomb 
repressive complex 2)
Euchromatic silencing Hs and Mm G9a
H3 K36 Transcriptional elongation and silencing Sc SET2
Transcriptional regulation Mm NSD1
H3 K79 Demarcation of euchromatin Sc and Hs DOT1 (a non-SET domain histone lysine methyltransferase)
H4 K20 Cell cycle-dependent silencing, mitosis and cytokinesis [52,53] Hs and Dm SET8
Heterochromatic silencing Dm, Mm, and Hs SUV4-20H1 and SUV4-20H2 [48]
Transcriptional regulation Mm NSD1
Transcriptional activation (in conjunction with ASH1-mediated  Dm ASH1
methylation of H3 K4 and H3 K9)
Recruitment of checkpoint protein Crb2 to sites of DNA damage Sp SET9 [49]
Histone lysine methylation sites, functions, and associated histone lysine methyltransferases, which are listed according to the lysine that they methylate.
*Species abbreviations: At, Arabidopsis thaliana; Dm, Drosophila melanogaster; Hs, Homo sapiens; Mm, Mus musculus; Nc, Neurospora crassa; Sc, Saccharomyces
cerevisiae; Sp, Schizosaccharomyces pombe. Adapted from [54-56]; additional references listed in the table are those not cited in these reviews.about 17.3 kilobases (kb) long (Figure 2c). GLP1 is 45%
identical to G9a and most of the divergence is in the
amino-terminal third of the protein. The GLP1 gene has
25 exons - it lacks homologs of the first three introns of
G9a - and the 20 exons from the 3 end have identical
junctions to those found in G9a. The GLP gene is quite
large, 120 kb in human and 92 kb in mouse, with introns
as long as 16 kb (Figure 2d). No obvious orthologs of G9a
or GLP can be found in the worm, frog or yeast genomes;
in the D. melanogaster genome there is one gene
(CAB65850) encoding a protein that is distantly related to
human G9a (20% identity) or GLP (18% identity) in the
carboxy-terminal half of the protein. The chicken genome
also encodes one protein (CAH65313) that shares 75%
identity with human GLP. Interestingly, both a frog
(Xenopus tropicalis) and three species of fish (D. rerio,
Tetraodon nigroviridis, and Takifugu rubripes) have both
G9a and GLP in their genomes, although most have not
yet been annotated as such. The zebrafish GLP ortholog
(CAE49087) is 45% identical to human GLP, and the gene
shares all but three of its 23 intron-exon junctions with
human GLP1.
G9a and SUV39H1 both belong to the same family of SET-
domain proteins and both have pre-SET and post-SET
domains surrounding the SET domain, but they do not share
any intron-exon junctions, even though a number of these
junctions occur within the highly conserved SET domain.
The other two SUV39 family proteins, ESET (also called
SETDB1) and CLLL8 (SETDB2) also have significant simi-
larities in their genomic structures with each other but not
with G9a or SUV39H1 (data not shown). Several proteins in
other SET families are also found in closely related pairs:
EZH1 and EZH2 (members of the EZ family), MLL1 (also
called HRX) and MLL2 (HRX2, both members of the SET1
family), SET1 and SET1L (SET1 family), NSD2 (WHSC1) and
NSD3 (WHSC1L1; SET2 family), and SUV4-20H1 and
SUV4-20H2 (SUV4-20 family).
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Figure 1
A protein sequence alignment of the SET domains of several representative histone lysine methyltransferases (HKMT) grouped according to their
histone-lysine specificity. All sequences are human with the exceptions of Saccharomyces cerevisiae SET1 and SET2, Schizosaccharomyces pombe CLR4, and
Neurospora DIM-5. See Table 2 for the family designations of each human protein shown. The alignment between SET7/9 and DIM-5 is based on their
structures [16]. The white text on a black background denotes invariant residues; black text on a gray background indicates conserved residues. The
involvement of invariant residues in binding to AdoMet and the target lysine, catalysis, the structural pseudoknot (see Figure 3), an intra-molecular
interacting salt bridge, and a F/Y switch controlling whether the product is a mono-, di- or tri-methylated histone [57] are indicated. 
Specificity      HKMT      Residue
H3-K4      SET7/9         214 ERVYVAESLISSAGEGLFSKVAVGPNTVMSFYNGVRITHQEVDSRD------WALNGNTLSLDE--------ETV
     SMYD3            2 EPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKG-SRGVVCDRCLLGKEKLMRCSQCRVAKY(119)
     MLL1          3827 SKEAVGVYRSPIHGRGLFCKRNIDAGEMVIEYAGNVIRSIQTDKREKYYDSKGIG-CYMFRIDDSE--------V
     SET1           936 RKKPVMFARSAIHNWGLYALDSIAAKEMIIEYVGERIRQPVAEMREKRYLKNGIGSSYLFRVDENT--------V
H3-K9      SUV39H1        242 RYDLCIFRTDDGRGWGVRTLEKIRKNSFVMEYVGEIITSEEAERRG--QIYDRQGATYLFDLDYVE-----DVYT
     DIM-5          148 TVPLQIFRTKD-RGWGVKCPVNIKRGQFVDRYLGEIITSEEADRRRAESTIARRKDVYLFALDKFSD(10)QPLE
     CLR4           327 TLPLEIFKTKE-KGWGVRSLRFAPAGTFITCYLGEVITSAEAAKR--DKNYDDDGITYLFDLDMFDDAS---EYT
     G9a           1037 KVRLQLYRTAK-MGWGVRALQTIPQGTFICEYVGELISDAEADVR--------EDDSYLFDLDNKDG----EVYC
H3-K27      EZH2           610 SKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCS--FLFNLNNDF--------V
H3-K36      SET2           119 YAPIAIFKTKH-KGYGVRAEQDIEANQFIYEYKGEVIEEMEFRDRLIDYDQRHFKHFYFMMLQNGE--------F
H4-K20 SET8           255 KEEGMKIDLIDGKGRGVIATKQFSRGDFVVEYHGDLIEITDAKKREALYAQDPSTGCYMYYFQYLS-----KTYC
Specificity      HKMT      Residue
H3-K4      SET7/9         282 IDVPEPYNHVSKYCASLGHKANHSFTPNCIYDMFVHPRF---GPIKCIRTLRAVEADEELTVAYGYDH
     SMYD3          191 QEVGVGLY-------PSISLLNHSCDPNCSIVFNGPH--------LLLRAVRDIEVGEELTICYLDML
     MLL1          3893 VDATMHGN--------RARFINHSCEPNCYSRVINIDGQKH----IVIFAMRKIYRGEELTYDYKFPI
     SET1          1003 IDATKKGG--------IARFINHCCDPNCTAKIIKVGGRRR----IVIYALRDIAASEELTYDYKFER
H3-K9      SUV39H1        310 VDAAYYGN--------ISHFVNHSCDPNLQVYNVFIDNLDERLPRIAFFATRTIRAGEELTFDYNMQV
     DIM-5          228 VDGEYMSG--------PTRFINHSCDPNMAIFARVGDHADKHIHDLALFAIKDIPKGTELTFDYVNGL
     CLR4           396 VDAQNYGD--------VSRFFNHSCSPNIAIYSAVRNHGFRTIYDLAFFAIKDIQPLEELTFDYAGAK
     G9a           1099 IDARYYGN--------ISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRF
H3-K27      EZH2           675 VDATRKGN--------KIRFANHSVNPNCYAKVMMVNGDHR----IGIFAKRAIQTGEELFFDYRYSQ
H3-K36      SET2           185 IDATIKGS--------LARFCNHSCSPNAYVNKWVVKDKLR----MGIFAQRKILKGEEITFDYNVDR
H4-K20 SET8           325 VDATRETN-------RLGRLINHSKCGNCQTKLHDIDGVPH----LILIASRDIAAGEELLYDYGDRS
AdoMet
AdoMet and
target Lys
Catalytic site
F/Y switch
F/Y switch
Pseudoknot
Salt bridge
AdoMet227.4 Genome Biology 2005, Volume 6, Issue 8, Article 227 Dillon et al. http://genomebiology.com/2005/6/8/227
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Table 2
Properties of some human SET-domain proteins
Domains common
to the family in  Domains unique  GenBank 
Chromosomal  Gene size Number of  Protein size  addition to the   to particular  accession
location (kb)  coding exons  (amino acids) SET domain members number
Pre-SET (9 Cys, 3 Zn), 
SUV39 family post-SET (CXCX4C) 
SUV39H1 Xp11.23 12.4 6 412 4 Cys, chromo 4507321
SUV39H2 10p13 24 6 477 (Mm)* 4 Cys, chromo 9956936
G9a 6p21.33 17.3 28 1,210 E/KR-rich, NRSF-binding, 18375637
ankyrin repeats
GLP1 (EuHMT1) 9q34.3 120 25 1,267 Same as G9a  20372683
ESET (SETDB1) 1q21.2 37 21 1,291 Tudor, MBD 505110
CLLL8 (SETDB2) 13q14.2 40 14 719 MBD 13994282
SET1 family Post-SET (CXCX4C)
MLL1 (HRX, ALL1) 11q23.3 86 36 3,969 AT hook, Bromo 1170364
PHD, CXXC
HRX2 (MLL4) 19q13.12 20 37 2,715 Same as above 12643900
ALR (MLL2) 12q13.12 34 54 5,262 PHD, ring finger 2358285
MLL3 7q36.1 299 58 4,911 PHD, ring finger 21427632
SET1 (ASH2) 16p11.2 26 18 1,707 RRM, poly-S/E/P 6683126
SET1L 12q24.31 14 11 1,092 (Mm)* RRM, poly-S/E/P 23468263 
Pre-SET (7-9 Cys);
SET2 family post-SET (CXCX4C) 
WHSC1 (NSD2) 4q16.3 79 21 1,365 PWWP, PHD, HMG,  6683809
ring finger
WHSCL1 (NSD3) 8p12 73 23 1,437 PWWP, PHD, 13699811
ring finger 
NSD1 5q35.3 160 23 2,696 PWWP, PHD, 19923586
ring finger
HIF1 (HYPB) 3p21.31 106 19 2,061 WW 12697196
ASH1 1q22 184 27 2,969 AT hook, bromo, 7739725
BAH, PHD
RIZ family
RIZ (PRDM2) 1p36.21 86 9 1,719 C2H2 zinc finger  9955379
BLIMP1 (PRDM1) 6q21 19 6 789 C2H2 zinc finger 3493158
SMYD family Post-SET (CXCX2C)
SMYD3 1q44 758 12 428 Zf-MYND 30913569
SMYD1 2p11.2 43 9 490 Zf-MYND 38093643
EZ family Pre-SET (~15 Cys)
EZH1 17q21.2 26 19 747 2 SANT 3334182
EZH2 7q36.1 40 19 746 2 SANT 3334180
SUV4-20 family Post-SET (CXCX2C)
SUV4-20H1 11q13.2 57 9 876 50659081
SUV4-20H2 19q13.42 8 8 462 31543168
Others
SET7/9 4q31.1 45 8 366 MORN 25091213
SET8 (PR-SET7) 12q24.31 26 8 393 25091219
The seven families of SET-domain proteins are classified according to the sequences surrounding their SET domain. *Complete human SUV39H2 and SET1L
cDNAs are not available in current databases, but partial cDNA and genomic sequences corresponding to the mouse sequences (Mm) are present. For the
pre-SET and post-SET domains, the number and (if known) the arrangement of cysteines in the domain is given. Domain abbreviations and definitions:
ankyrin repeats, tandemly repeated modules of about 33 amino acids; AT hook, DNA binding motif with a preference for A/T-rich regions; BAH, Bromo
adjacent homology domain; bromo, bromodomain, which can interact specifically with acetylated lysines; chromo, chromatin organization modifier domain;
CXXC, domain with two cysteines separated by two amino acids; E/KR-rich, glutamine- or lysine/arginine-rich domains; HMG, high mobility group domain;
MBD, methyl-binding domain; MORN, membrane occupation and recognition nexus repeat; NRSF-binding, binds neuron-restrictive silencing factor/repressor
element 1 silencing transcription factor; PHD, folds into an interleaved type of Zn-finger chelating two Zn ions; poly-S/E/P, runs of serine, glutamate or
proline; PWWP, domain including a conserved Pro-Trp-Trp-Pro motif; RRM, RNA recognition motif; SANT, DNA-binding domain that specifically
recognizes the sequence YAAC(G/T)G; Tudor, domain of unknown function present in several RNA-binding proteins; WW, contains two highly conserved
tryptophans and binds proline-rich peptide motifs; Zf-MYND, ‘myeloid, Nervy, DEAF-1’ domain consisting of a cluster of cysteine and histidine residues. Characteristic structural features
The structures of SET-domain proteins that are currently
known include: the crystal structures of two members of
the SUV39 family, Neurospora crassa Decrease in DNA
methylation 5 (DIM-5) [15,16] and S. pombe CLR4 [17];
four structures of human SET7/9 in various configurations
[18-21]; a nuclear magnetic resonance (NMR) structure of
a viral protein that contains only the SET domain [22]; and
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Figure 2
Schematic representations of the gene and primary protein structures of two pairs of related SET-domain histone methyltransferases in the SUV39
family. (a) Human SUV39H1 (gene, mRNA and protein); (b) human SUV39H2 (gene and mRNA for comparison with SUV39H1); (c) human G9a (gene,
mRNA and protein); (d) human GLP1 (EuHMT1; mRNA for comparison with G9a; the gene structure is not shown because of the large size of the
intron). Black boxes in the genes and white boxes in the mRNAs denote exons; numbers above each gene are exon numbers; numbers within exons
indicates their size in nucleotides; thin lines in the genes indicate the introns and untranslated regions of the first and the last exons (these are shown to
scale with the length of the exons except where lines are broken). (a,c) Protein structures are shown on the same scale as the coding region of the
corresponding mRNA, so that the corresponding exons for each protein domain can be directly aligned. Domains are indicated above protein structures,
and the number of conserved cysteines (Cys) in each domain is also shown. Abbreviations: Chromo, chromodomain; E-rich, glutamine-rich domain;
KR-rich, domain rich in lysine and arginine; NRSF-binding, a domain involved in binding neuron-restrictive silencing factor/repressor element 1 silencing
transcription factor. (c,d) The intron-exon junctions indicated with asterisks are those that differ between G9a and GLP1.
12 3 4 5 6
43 19 146 663 147 130 131 1,140
(a) SUV39H1
(b) SUV39H2
1 (2) 3 4 56
? 31 145 672 147 130 104 560
Gene 5′
mRNA
3′
N
N
C Protein
7 31 42 93 142 242 365 399 412
4 Cys Chromo Pre-SET (9 Cys)  SET Post-SET (3 Cys) 
(c) G9a
12 3 4 5 7 68 9
10
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12
14 13 15 16
17
18 19
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359 ?
42
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41
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** * * * *
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** *
mRNA
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E-rich    KR-rich   
NRSF-binding
(12 Cys) Ankyrin repeats Pre-SET SET Post-SET
1
C Protein
Gene 5′
mRNA
3′
Gene 5′
mRNA
3′a structure of the non-histone protein methyltransferase
Rubisco LSMT, an unclassified member of the superfamily
[23,24]. These structures revealed that the SET domain
forms a novel  fold not seen in any other previously charac-
terized AdoMet-dependent methyltransferases (reviewed in
[25]). The fold has a series of curved  strands forming
several small sheets, packed together with pre-SET (or
N-SET) and post-SET (or C-SET) domains or regions (Figure
3). The pre-SET domain of SUV39-family proteins (see
Table 2) contains nine invariant cysteine residues that are
grouped into two segments of five and four cysteines sepa-
rated by various numbers of amino acids (CXCX5CX4CXC-
XN-CX3CXCX3C, where N is 46 in DIM-5 and 28 in CLR4).
The nine cysteines of the pre-SET domain of DIM-5 coordi-
nate three zinc ions to form an equilateral triangular cluster,
Zn3Cys9 (Figure 3a). The SET domain, which may have
evolved through the duplication of a three-stranded unit
[26], is folded in all the solved structures into several small 
sheets surrounding a knot-like structure by threading of the
carboxyl terminus through an opening of a short loop
formed by a preceding stretch of the sequence (Figure 3).
This remarkable ‘pseudoknot’ fold brings together the two
most-conserved sequence motifs of the SET domain (RFIN-
HXCXPN and ELXFDY; see Figure 1) to form an active site
in a location immediately next to the pocket where the
methyl donor binds and to the peptide-binding cleft. 
The post-SET region of DIM-5 contains three conserved cys-
teine residues, arranged CXCX4C, that are essential for its
histone lysine methyltransferase activity [15]. The structure
of DIM-5 in a ternary complex with an H3 K9 peptide and
AdoHcy [16] reveals that, as expected from their arrange-
ment, these three post-SET-domain cysteines coordinate a
zinc ion tetrahedrally together with cysteine 244 of the SET-
domain signature motif RFINHXCXPN in the pseudoknot
near the active site (Figure 3a). Consequently, a narrow
channel is formed to accommodate the side chain of the
target lysine. Three ternary structures - SET7/9 in complex
with a peptide containing histone H3 K4 [21], DIM-5 in
complex with a histone H3 K9 peptide [16], and Rubisco
LSMT in complex with a free lysine [24] - reveal that the
target lysine is inserted into a narrow channel so that the
target nitrogen would be in close proximity to the methyl
donor AdoMet at the opposite end of the channel.
Close examination of the region carboxy-terminal to the SET
domain in many proteins, including members of the SUV39,
SET1, and SET2 families, suggests that the post-SET-domain
metal center observed in DIM-5 is universal among all those
members of the superfamily that have the cysteine-rich post-
SET domain. For almost all SET-domain proteins, there
appears to be an absolute correlation between the presence of
the post-SET domain and a cysteine corresponding to Cys244
of DIM-5 near the active site. Comparison of DIM-5 with
SET7/9 [19,21] and the Rubisco LSMT [23,24], two SET-
domain proteins that do not have Cys-rich pre-SET and
post-SET domains, reveals a remarkable example of conver-
gent evolution. In particular, as in DIM-5, these two enzymes
rely on residues carboxy-terminal to the SET domain for the
formation of lysine channel, but they do so by packing of an 
helix, rather than a metal center, onto the active site.
Localization and function
The lysine -amino groups of histones can be mono-, di-, or
tri-methylated and, depending on the specific residue(s)
modified, this methylation is associated with the formation
of repressive heterochromatin, with transcriptional activa-
tion and elongation by RNA polymerase II or with the tran-
scriptional silencing of euchromatic genes (Table 1). In
heterochromatin, the H3 K9 methyl mark is recognized by
heterochromatin protein 1 (HP1) in mammals and its
homolog Swi6 in S. pombe; these proteins bind to the modi-
fied residue via their chromodomains, a domain shared by
many regulators of chromatin structure [27,28], resulting in
the formation of transcriptionally silent heterochromatin.
Methylation of H3 K9 and H3 K27 is also associated with
transcriptional silencing in euchromatin [29]. In contrast,
di- and tri-methylation of Lys4 on the same histone (H3 K4)
is associated with active transcription [30].
The Saccharomyces cerevisiae SET1 and SET2 complexes are
involved in transcriptional elongation as part of the RNA
polymerase II holoenzyme [31,32]. Tri-methylation of H3 K4
by SET1 is associated with regions of each gene that are tran-
scribed early, in contrast to the SET2-mediated methylation
of H3 K36, which is associated with downstream regions that
are transcribed in the later stages of transcriptional elonga-
tion. The mammalian nuclear-receptor-binding SET-domain-
containing protein (NSD1, a member of the SET2 family) has
been found to play a crucial role in post-implantation devel-
opment, methylating H3 K36 and H4 K20 [33]. ESET (also
called SETDB1), which predominantly methylates H3 K9 in
transcriptionally silent euchromatin, is also required for peri-
implantation development [34]. ESET has been reported to
bind the co-repressor KAP-1, which acts as a molecular scaf-
fold, targeting ESET and HP1 to euchromatic genes silenced
by KRAB-domain zinc-finger proteins [35]. 
Human SET7/9 mono-methylates H3 K4 [16,21], whereas 
S. cerevisiae SET1 di- or tri-methylates the same residue
[36]. The strict lysine specificity of these enzymes is in dis-
tinct contrast to Drosophila ASH1 (a member of the SET1
family), mammalian G9a, human EZH1 and EZH2 and
mouse NSD1, enzymes that can methylate two or more dif-
ferent lysine residues (Table 1). In some cases, the functions
of SET-domain enzymes are not confined to histone methy-
lation. For instance, human SET7/9 has recently been
reported to methylate Lys189 in the general transcription
factor TAF10, resulting in an increased affinity for RNA
polymerase II and transcriptional activation of certain
TAF10-dependent genes [37]. SET7/9 has also been reported
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tumor-suppressor protein [38]. These observations suggest
that we should not narrowly define the SET-domain proteins
as histone lysine methyltransferases but instead call them
protein lysine methyltransferases.
DIM-5 tri-methylates H3 K9 [16], and this marks chromatin
regions for DNA methylation [39]. Other members of the
SUV39 family - KRYPTONITE of Arabidopsis thaliana
[40,41], Suv39h1 of mouse [42], and mammalian G9a [43] -
have been implicated in DNA methylation. In contrast to the
tri-methylation of H3 K9 by which DIM-5 marks regions for
DNA methylation [39], the critical mark for DNA methyla-
tion by KRYPTONITE is di-methylation of H3 K9 [40].
Mechanism
SET-domain proteins differ from other AdoMet-dependent
methyltransferases in several respects; most notably, the
binding sites for the histone substrate and AdoMet are
located on opposite faces of the SET domain (Figure 4). The
substrate-binding clefts are connected through a deep
channel that runs through the core of the SET domain and
permits transfer of the methyl group from AdoMet to the -
amino group of the lysine substrate. This unusual arrange-
ment of the substrate binding sites was originally proposed
to permit multiple rounds of lysine methylation without dis-
sociation of the protein substrate from the SET domain [23].
Subsequent biochemical studies of SET-domain methyl-
transferases such as the histone H3 K9 tri-methylase DIM-5
[16] have supported this model of processive lysine methyla-
tion by members of the superfamily.
The crystal structures of N. crassa DIM-5 [15], human
SET7/9 [18,19,21], and pea Rubisco LSMT [23] have
revealed that the AdoMet-binding pocket is structurally con-
served among SET-domain methyltransferases. The con-
served G-X-G motif (in which X is generally a bulky
hydrophobic residue) and the asparagine and histidine of the
RFINHXCXPN motif (Figure 1) engage in hydrogen-bond
and van der Waals interactions with the cofactor (Figure 4a).
In addition, a positively charged residue that is structurally
conserved in the cofactor binding site but is not conserved
within the SET domain sequence forms a salt bridge with the
carboxylate of AdoMet, as illustrated by the interactions
between the cofactor and the side chain of Lys294 in SET7/9
(Figure 4a). Finally, the side chain of an aromatic residue
from the C-SET or post-SET region forms an interaction
involving stacking of aromatic  rings with the adenine
moiety of AdoMet. The cumulative effect of these interac-
tions causes AdoMet to adopt a horseshoe-shaped conforma-
tion, positioning the labile methyl group into the
methyltransfer pore that links the cofactor-binding and
lysine-binding sites. 
The crystal structures of the ternary complexes of SET7/9
[21] and DIM-5 [16], respectively bound to AdoHcy and
histone H3 peptides have yielded insights into the catalytic
mechanism of the SET-domain methyltransferases. In both
proteins, the walls of the lysine-binding channel are formed
by hydrophobic residues that engage in van der Waals inter-
actions with the lysine side chain (Figure 4b,c). At the base
of the channel is the methyltransfer pore, which connects the
pocket to the AdoMet-binding cleft. This pore is rimmed
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Figure 3
Representative examples of SET-domain-containing structures. (a) Neurospora crassa DIM-5 (Protein DataBank (PDB) code 1PEG.pdb); (b) human
SET7/9 (1O9S.pdb). The pre-SET, SET, and post-SET domains in DIM-5 and the N-SET, SET, and C-SET domains in SET7/9 are indicated. The pseudoknot
formed by two conserved SET motifs and the bound histone H3 peptide are also illustrated. The reaction byproduct AdoHcy is in stick representation
and the zinc ions are shown as balls. N, amino terminus; C, carboxyl terminus.
AdoHcy
AdoHcy
Post-SET
N
C
Pre-SET
DIM-5 SET7/9
C-SET N-SET
N
C
SET
SET
H3
H3
Pseudo
knot
Pseudo
knot
(a) (b)with several structurally conserved carbonyl oxygens as well
as the hydroxyl group of the invariant tyrosine from the
carboxyl terminus of the SET domain (Figure 1). These
carbonyl and hydroxyl oxygens have been proposed to
facilitate the transfer of the methyl group during catalysis
[16,21,24]. In addition, tyrosine residues in the lysine-
binding clefts of SET7/9 (Tyr245 and Tyr305) and DIM-5
(Tyr178) hydrogen-bond to the lysine -amino group, aligning
it for a methyltransfer with AdoMet (Figure 4b,c). Mutation
of Tyr245 or Tyr305 in SET7/9 (Figure 4b) alters its specificity
from an H3 K4 mono-methylase to a tri- and di-methylase,
respectively [16,21], whereas an Phe281Tyr mutation in the
lysine-binding pocket of DIM-5 (Figure 4c) converts this
protein to an H3 K9 mono- or di-methylase [16]. These muta-
tions exemplify the F/Y switch (Figure 1) that establishes SET-
domain product specificities. Taken together, these results
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Figure 4 
Structures of the active sites of SET-domain protein methyltransferases. Hydrogen bonds are rendered as dashed lines and residue numbers are indicated
in the single-letter amino-acid code. (a-c) The carbon atoms of substrates and products are illustrated in purple to distinguish them from protein
residues (gray). (a) The cofactor-binding site of SET7/9 with bound AdoMet (PDB code 1N6A.pdb). (b) The lysine-binding pocket of SET7/9 in complex
with methylated K4 (MeK4) of histone H3 from the crystal structure of the ternary complex SET7/9:AdoHcy:histone H3 MeK4 peptide (1O9S.pdb). (c)
The lysine-binding channel of DIM-5 bound to K9 of histone H3 from the structure of the ternary complex DIM-5:AdoHcy:histone H3 peptide
(1PEG.pdb). (d,e) Protein-substrate-binding clefts of SET-domain protein methyltransferases. The binding sites are rendered as transparent molecular
surfaces. For clarity, the carbon atoms of histone H3 are depicted in cyan and the enzymes in green. (d) The protein-substrate-binding site of SET7/9 in
complex with a histone H3 peptide from the structure of the ternary complex (1O9S.pdb). The white area is the methyltransfer pore. (e) Substrate-
binding cleft of DIM-5 bound to a histone H3 peptide from the ternary complex structure (1PEG.pdb).
(a)
(d) (e)
(b) (c)
SET7/9 with histone H3 DIM-5 with histone H3
SET7/9:AdoHcy with
Mek4 of histone H3
SET7/9:AdoMet DIM-5:AdoHcy with
K9 of histone H3have yielded insights into the catalytic mechanism and
methyltransfer specificity of SET-domain methyltransferases.
The crystal structures of SET7/9 [21] and DIM-5 [16] bound
to peptide fragments of histone H3 have also revealed the
determinants for methylation of K4 and K9, respectively.
The two enzymes bind to their cognate histone methylation
sites in a structurally analogous orientation. The histone
substrate binds in an extended conformation in a groove
formed by the 6 strand and the loop exiting the thread-loop
motif in the carboxyl terminus of the SET domain (Figure
4d,e). The backbone of the histone peptide is anchored in
this site by forming a short parallel  sheet with the 6
strand. Specificity for methylation of Lys4 and Lys9 in
histone H3 is achieved through recognition of the residues
flanking each lysine residue. Residues Arg2, Thr3, and Gln5
in histone H3 are recognized through hydrogen bonds in the
substrate binding cleft of SET7/9 [20] (Figure 4d). In con-
trast, only the side chain of Ser10 in histone H3 is recognized
by DIM-5 through a hydrogen bond to Asp209 in the histone-
binding cleft [16] (Figure 4e). To compensate for the lack of
side-chain interactions, the substrate-binding site of DIM-5
engages in a more extensive -sheet hydrogen bonding with
the backbone of histone H3 than does the substrate-binding
site of SET7/9. Collectively, the crystallographic studies of
SET7/9 and DIM-5 bound to histone H3 peptides have
provided a framework for understanding the histone lysine
specificity of different SET-domain enzymes. 
Frontiers
As the function of SET-domain proteins become clearer, it is
apparent that they can also be perturbed in disease. The
recent recognition of the role played by the SET-domain
protein SMYD3 in the proliferation of colorectal and hepato-
cellular carcinomas [44] may pave the way for the develop-
ment of specific inhibitors of SMYD3 activity in cancer
treatment. SMYD3 expression is upregulated in these
cancers, and its histone H3 K4 methyltransferase activity
activates oncogenes and other genes associated with the cell
cycle. MLL1, the human homolog of Drosophila Trx and a
member of the SET1 family, is often implicated in leukemia
as a result of aberrant Hox gene activation mediated by
histone H3 K4 methylation [45]. Moreover, EZH2 is
involved in metastatic prostate and breast cancer [46,47],
suggesting that identification and targeted inhibition of SET-
domain proteins involved in cancer may be useful for the
treatment of patients in the future. The recent identification
and characterization of two new SET-domain methyltrans-
ferases, SUV4-20H1 and SUV4-20H2, which function in H4
K20 tri-methylation [48], suggests that more SET-domain
methyltransferases await characterization. In addition, the
previously uncharacterized S. pombe SET9 protein has
recently been shown to be able to methylate H4 K20 [49].
This modification does not seem to play a role in controlling
gene expression or heterochromatin formation, but rather
appears to be responsible for the recruitment of the check-
point protein Crb2 to sites of DNA damage, unveiling yet
another role for SET-domain proteins. The recent identifica-
tion of the first histone demethylase, LSD1, which is con-
served from S. pombe to humans, reveals that regulation of
histone methylation is even more dynamic than was thought
[50]. More recently, evidence has been provided that a
cytosolic EZH2-associated methyltransferase complex regu-
lates actin polymerization in various cell types, suggesting
that SET-domain proteins may have many different roles in
the cell [51].
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